APA (7th ed.) Citation

Petrova, E. M., Cheraneva, V. A., & Grachev, V. G. (2021). Hepatogenic weakness as a clinical marker of hyperammonemia and of the effectiveness of its correction in patients with pre-cirrhotic stages of non-alcoholic fatty liver disease. Open Systems Publication.

Chicago Style (17th ed.) Citation

Petrova, E. M., V. A. Cheraneva, and V. G. Grachev. Hepatogenic Weakness as a Clinical Marker of Hyperammonemia and of the Effectiveness of Its Correction in Patients with Pre-cirrhotic Stages of Non-alcoholic Fatty Liver Disease. Open Systems Publication, 2021.

MLA (9th ed.) Citation

Petrova, E. M., et al. Hepatogenic Weakness as a Clinical Marker of Hyperammonemia and of the Effectiveness of Its Correction in Patients with Pre-cirrhotic Stages of Non-alcoholic Fatty Liver Disease. Open Systems Publication, 2021.